Johnson & Johnson Innovation - JJDC, Inc. - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 43 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
Johnson & Johnson Innovation - JJDC, Inc. ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$545,000
-21.1%
84,0030.0%0.06%
-37.1%
Q1 2021$691,000
-29.7%
84,0030.0%0.09%
-29.9%
Q4 2020$983,000
+126.5%
84,0030.0%0.13%
+46.0%
Q3 2020$434,000
+163.0%
84,0030.0%0.09%
+171.9%
Q2 2020$165,000
+15.4%
84,0030.0%0.03%
-59.0%
Q1 2020$143,000
-27.4%
84,0030.0%0.08%
+9.9%
Q4 2019$197,00084,0030.07%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$848,0820.28%
Ikarian Capital, LLC 2,765,530$492,2650.06%
JOHNSON & JOHNSON 84,003$14,9530.01%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$46,0740.00%
BlackRock Inc. 267,821$47,6730.00%
Bank of New York Mellon Corp 10,259$1,8260.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15,835$2,8190.00%
Truvestments Capital LLC 318$570.00%
Tower Research Capital LLC (TRC) 10,407$1,8520.00%
Cutler Group LLC / CA 1,200$00.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders